Last reviewed · How we verify

NCT07030361: DialysisSuit

Intradıalytıc Weıght Control In Hemodıalysıs Patıents

Completed NA Last updated 22 June 2025
What this trial tests

NA trial testing suit group in Fluid Overload in 66 participants. Completed in 30 September 2023.

Timeline
22 February 2023
Primary endpoint
5 July 2023
30 September 2023

Quick facts

Lead sponsorBalikesir University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposesupportive care
Enrollment66
Start date22 February 2023
Primary completion5 July 2023
Estimated completion30 September 2023
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Balikesir University

Who can join

Adults 18 to 80, any sex, with Fluid Overload. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this observational study is to determine the effect of a dialysis gown designed according to the empowerment model on changes in weight control behaviors among gown group patients during the intradialytic period. The main question it seeks to answer is: • Is the dialysis gown effective in helping gown group patients control their fluid intake during the intradialytic period?

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Fluid Overload

Currently open trials in the same condition.

Other Balikesir University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07030361.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing